Anti-Cardiac FABP antibody [67D3]
| Name | Anti-Cardiac FABP antibody [67D3] |
|---|---|
| Supplier | Abcam |
| Catalog | ab16916 |
| Prices | $384.00 |
| Sizes | 500 µl |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Clone | 67D3 |
| Applications | IHC-F IP IHC-P WB |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Full length native protein (purified) (Human) |
| Description | Mouse Monoclonal |
| Gene | FABP3 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
IHC image of cardiac FABP staining in Human normal heart muscle formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab16916, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
Product References
Myocardial steatosis and necrosis in atria and ventricles of rats given pyruvate - Myocardial steatosis and necrosis in atria and ventricles of rats given pyruvate
Jones HB, Reens J, Johnson E, Brocklehurst S, Slater I. Toxicol Pathol. 2014 Dec;42(8):1250-66.
Heart-type fatty acid binding protein is associated with proteinuria in obesity. - Heart-type fatty acid binding protein is associated with proteinuria in obesity.
Chen HM, Zheng CX, Gao Q, Ge YC, Liu ZH. PLoS One. 2012;7(9):e45691.
Adenosine monophosphate-activated protein kinase activation, substrate - Adenosine monophosphate-activated protein kinase activation, substrate
Heather LC, Cole MA, Atherton HJ, Coumans WA, Evans RD, Tyler DJ, Glatz JF, Luiken JJ, Clarke K. Endocrinology. 2010 Jan;151(1):422-31.
Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form - Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form
Nevo J, Mattila E, Pellinen T, Yamamoto DL, Sara H, Iljin K, Kallioniemi O, Bono P, Heikkila P, Joensuu H, Warri A, Ivaska J. Clin Cancer Res. 2009 Nov 1;15(21):6570-81.